Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Dec 22;60(7):3388–3397. doi: 10.1093/rheumatology/keaa793

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Rheumatology.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com

PMC Copyright notice

graphic file with name keaa793f5.jpg — Fig. 5 Proteinuria at T₀ and modifications during the follow-up in anti-ENO1 positive and negative LN patients

Proteinuria at T₀ and % changes during the first 12 months of follow-up are reported for patients positive and negative for anti-ENO1. In the former case (proteinuria levels) a statistical difference was observed between the two groups. Also, the decrement of proteinuria was more evident in anti-ENO1 positive patients. The same parameters are reported sub-dividing the whole LN group in respect to positivity for anti-dsDNA IgG2.